Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Mantle cell lymphoma (MCL): Ibrutinib (Imbruvica) is indicated for the treatment of adult patients with MCL who have received at least one prior therapy.
Chronic lymphocytic leukemia/Small lymphocytic lymphoma (CLL/SLL): Ibrutinib (Imbruvica) is indicated for the treatment of patients with CLL/SLL.
Chronic lymphocytic leukemia/Small lymphocytic lymphoma with deletion 17p: Ibrutinib (Imbruvica) is indicated for the treatment of patients with CLL/SLL with deletion 17p.
Waldenström's macroglobulinemia (WM) Ibrutinib (Imbruvica) is indicated for the treatment of patients with WM.

Imbruvica Indications/Uses

ibrutinib

Manufacturer:

Catalent CTS

Distributor:

Johnson & Johnson